Keyword: Turku Bioscience Centre
Open Access Technology Centres Transform the Way Research Is Conducted — Turku Bioscience Operates at the Frontiers of Science
Among all the branches of life sciences, cell and molecular biology have often relied upon the development of key enabling technologies. Several significant paradigm shifts in biosciences have their origins specifically in novel and innovative technologies and/or methods.
Using cutting-edge genomics methods a gene signature predicting type 1 diabetes was discovered. This signature is detectable already before the appearance of type 1 diabetes associated autoantibodies. The finding could help in identifying early on the children who are likely to develop the disease later.
Researchers from Turku Bioscience Centre Identified Novel Oncogenic Function for Receptor Linked with Alzheimer’s Disease
Common and rare SORLA single nucleotide polymorphisms have been associated with the development of Alzheimer’s disease. So far, SORLA has been mainly studied in neurons, but the new study focused on the role of SORLA in cancer cells. Led by Academy Professor Johanna Ivaska, the research group observed that SORLA was highly expressed in HER2 positive cancers. Removing SORLA from cancer cells severely impaired the oncogenic fitness of HER2 positive cancers.
Turku Centre for Biotechnology Celebrates 30-year Anniversary and Strengthens Role as International Cluster of Expertise
Turku Centre for Biotechnology, a joint unit of the University of Turku and Åbo Akademi University, celebrating its 30-year anniversary offers technology services and produces top research in biosciences. In honour of the anniversary, the name of the Centre was changed to gain more visibility and to strengthen its position at the heart of technology services in Turku. In the future, the Centre's brand name will be Turku Bioscience – in Finnish, Turun biotiedekeskus.
Research Director Laura Elo from Turku Centre for Biotechnology receives the international Rising Talent Award of the For Women in Science programme granted by the L’Oréal Foundation and UNESCO. The recognition is awarded to 15 most promising women researchers from all over the world. The recognition is awarded on Thursday, 14 March in Paris.
The research groups of Academy Professor Riitta Lahesmaa and Research Director Laura Elo from Turku Centre for Biotechnology have discovered new proteins that regulate T cells in the human immune system. Some of these proteins can provide possible new targets for drug development in treating immune-mediated diseases.
Call for applications for doctoral candidate positions and for a right to study for a doctoral degree
Call for applications for fixed-term doctoral candidate positions and also for a right to study for a doctoral degree at the Faculty of Medicine will open on September 3, 2018. Period for applying is September 3– 21, 2018.